Early prediction of COVID-19-associated acute kidney injury: Are serum NGAL and serum Cystatin C levels better than serum creatinine?

NP Shakked, MHS de Oliveira, I Cheruiyot, JL Benoit… - Clinical …, 2022 - Elsevier
Abstract Background Coronavirus disease-2019 (COVID-19) is associated with a high risk of
acute kidney injury (AKI), often requiring renal replacement therapy (RRT). Serum Cystatin C
(sCysC) and serum Neutrophil Gelatinase-Associated Lipocalin (sNGAL) are emerging
biomarkers for kidney injury, and were suggested to be superior to serum creatinine (sCr) in
several clinical settings. Moreover, elevated sCysC is associated with disease severity and
mortality in COVID-19. We aimed to assess the utility of sCysC and sNGAL for predicting …

Early prediction of COVID-19-associated acute kidney injury: Are serum NGAL and serum Cystatin C levels better than serum creatinine?

MHS de Oliveira, I Cheruiyot, JL Benoit… - Clinical …, 2022 - europepmc.org
Background Coronavirus disease-2019 (COVID-19) is associated with a high risk of acute
kidney injury (AKI), often requiring renal replacement therapy (RRT). Serum Cystatin C
(sCysC) and serum Neutrophil Gelatinase-Associated Lipocalin (sNGAL) are emerging
biomarkers for kidney injury, and were suggested to be superior to serum creatinine (sCr) in
several clinical settings. Moreover, elevated sCysC is associated with disease severity and
mortality in COVID-19. We aimed to assess the utility of sCysC and sNGAL for predicting …
以上显示的是最相近的搜索结果。 查看全部搜索结果